BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gornik HL, Gerhard-Herman M, Beckman JA. Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. J Clin Oncol 2005;23:5211-6. [PMID: 16051963 DOI: 10.1200/JCO.2005.00.745] [Cited by in Crossref: 77] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Ahmed T, Mouhayar E, Song J, Koutroumpakis E, Palaskas NL, Yusuf SW, Lopez-mattei J, Hassan SA, Kim P, Cilingiroglu M, Marmagkiolis K, Vaporciyan AA, Swisher S, Deswal A, Iliescu C. Predictors of Recurrence and Survival in Cancer Patients With Pericardial Effusion Requiring Pericardiocentesis. Front Cardiovasc Med 2022;9:916325. [DOI: 10.3389/fcvm.2022.916325] [Reference Citation Analysis]
2 Rahman AU, Folaranmi O, Chan V, Chaudary A. Anaplastic Lymphoma Kinase-Positive Primary Lung Adenocarcinoma Presenting With Pericardial Effusion and Tamponade in a COVID-19 Patient: A Case Report. Cureus 2021;13:e19127. [PMID: 34868767 DOI: 10.7759/cureus.19127] [Reference Citation Analysis]
3 Zhou C, Li S, Liu J, Chu Q, Miao L, Cai L, Cai X, Chen Y, Cui F, Dong Y, Dong W, Fang W, He Y, Li W, Li M, Liang W, Lin G, Lin J, Lin X, Liu H, Liu M, Mu X, Hu Y, Hu J, Jin Y, Li Z, Qin Y, Ren S, Sun G, Shen Y, Su C, Tang K, Wu L, Wang M, Wang H, Wang K, Wang Y, Wang P, Wang H, Wang Q, Wang Z, Xie X, Xie Z, Xu X, Xu F, Yang M, Yang B, Yi X, Ye X, Ye F, Yu Z, Yue D, Zhang B, Zhang J, Zhang J, Zhang X, Zhang W, Zhao W, Zhu B, Zhu Z, Zhong W, Bai C, Chen L, Han B, Hu C, Lu S, Li W, Song Y, Wang J, Zhou C, Zhou J, Zhou Y, Saito Y, Ichiki Y, Igai H, Watanabe S, Bravaccini S, Fiorelli A, Petrella F, Nakada T, Solli P, Tsoukalas N, Kataoka Y, Goto T, Berardi R, He J, Zhong N. International consensus on severe lung cancer-the first edition. Transl Lung Cancer Res 2021;10:2633-66. [PMID: 34295668 DOI: 10.21037/tlcr-21-467] [Reference Citation Analysis]
4 Lestuzzi C. Neoplastic pericardial disease: Old and current strategies for diagnosis and management. World J Cardiol 2010; 2(9): 270-279 [PMID: 21160603 DOI: 10.4330/wjc.v2.i9.270] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
5 Jeong TD, Jang S, Park CJ, Chi HS. Prognostic relevance of pericardial effusion in patients with malignant diseases. Korean J Hematol 2012;47:237-8. [PMID: 23071482 DOI: 10.5045/kjh.2012.47.3.237] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
6 Pabba K, Rojas-Hernandez CM. Concurrent presentation of a hemorrhagic pericardial effusion and venous thromboembolism in malignancy: a systematic review of case studies. J Thromb Thrombolysis 2019;48:454-8. [PMID: 31134447 DOI: 10.1007/s11239-019-01884-z] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Hasegawa T, Arai Y, Sone M, Sugawara S, Itou C, Wada S, Umakoshi N, Kubo T, Kimura S, Kusumoto M. Clinical outcomes of image-guided percutaneous drainage of pericardial effusion in cancer patients: A single-center retrospective analysis. Asia Pac J Clin Oncol 2022. [PMID: 35831984 DOI: 10.1111/ajco.13810] [Reference Citation Analysis]
8 Imai H, Kaira K, Masubuchi K, Minato K. Management of Lung Cancer-Associated Malignant Pericardial Effusion with Intrapericardial Administration of Carboplatin: A Retrospective Study. Current Oncology 2022;29:163-72. [DOI: 10.3390/curroncol29010015] [Reference Citation Analysis]
9 Kunitoh H, Tamura T, Shibata T, Imai M, Nishiwaki Y, Nishio M, Yokoyama A, Watanabe K, Noda K, Saijo N; JCOG Lung Cancer Study Group, Tokyo, Japan. A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811). Br J Cancer 2009;100:464-9. [PMID: 19156149 DOI: 10.1038/sj.bjc.6604866] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
10 Ueda T, Tsubamoto H, Eguchi A, Terada T, Shibahara H. Bevacizumab helped resolve pericardial and pleural effusion that was associated with malignant ovarian clear cell carcinoma. Gynecol Oncol Rep 2016;16:11-3. [PMID: 27331128 DOI: 10.1016/j.gore.2016.01.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
11 Tyebally S, Ghose A, Chen DH, Abiodun AT, Ghosh AK. Chest Pain in the Cancer Patient. Eur Cardiol 2022;17:e15. [DOI: 10.15420/ecr.2021.45] [Reference Citation Analysis]
12 Montañez-Valverde RA, Olarte NI, Zablah G, Hurtado-de-Mendoza D, Colombo R. Swinging heart caused by diffuse large B-cell lymphoma. Oxf Med Case Reports 2018;2018:omy075. [PMID: 30159160 DOI: 10.1093/omcr/omy075] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Nakamura T, Okune M, Yasuda M, Watanabe H, Ueno M, Yamaji K, Mizutani K, Kurita T, Nakazawa G. Impact of pericardial fluid glucose level and computed tomography attenuation values on diagnosis of malignancy-related pericardial effusion. BMC Cardiovasc Disord 2021;21:272. [PMID: 34082695 DOI: 10.1186/s12872-021-02091-6] [Reference Citation Analysis]
14 Kotake M, Imai H, Kaira K, Fujisawa T, Yanagita Y, Minato K. Intrapericardial carboplatin in the management of malignant pericardial effusion in breast cancer: a pilot study. Cancer Chemother Pharmacol 2019;84:655-60. [PMID: 31250155 DOI: 10.1007/s00280-019-03897-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Cagle LA, Epstein SE, Owens SD, Mellema MS, Hopper K, Burton AG. Diagnostic yield of cytologic analysis of pericardial effusion in dogs. J Vet Intern Med 2014;28:66-71. [PMID: 24236526 DOI: 10.1111/jvim.12253] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
16 Shiryaev AA, Minaev VV, Stolyarov VI, Efendiev KT, Fatyanova AS, Zhemerikin GA, Agakina YS, Aleynikova AR, Shchekoturov IO, Parshin VD, Reshetov IV, Loschenov VB. A Method for Intra-percardial PDT for Malignant Mesothelioma. Photodiagnosis Photodyn Ther 2022;:102799. [PMID: 35276346 DOI: 10.1016/j.pdpdt.2022.102799] [Reference Citation Analysis]
17 Sadiq AM, Sadiq AM, Nkya GZ. Advanced lung cancer presenting with malignant pericardial effusion. Clin Case Rep 2021;9:e04179. [PMID: 34194771 DOI: 10.1002/ccr3.4179] [Reference Citation Analysis]
18 Rooper LM, Ali SZ, Olson MT. A Minimum Volume of More Than 60 mL Is Necessary for Adequate Cytologic Diagnosis of Malignant Pericardial Effusions. Am J Clin Pathol 2016;145:101-6. [PMID: 26712877 DOI: 10.1093/ajcp/aqv021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
19 Kim SH, Kwak MH, Park S, Kim HJ, Lee HS, Kim MS, Lee JM, Zo JI, Ro JS, Lee JS. Clinical characteristics of malignant pericardial effusion associated with recurrence and survival. Cancer Res Treat 2010;42:210-6. [PMID: 21253323 DOI: 10.4143/crt.2010.42.4.210] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
20 Refaat MM, Katz WE. Neoplastic pericardial effusion. Clin Cardiol. 2011;34:593-598. [PMID: 21928406 DOI: 10.1002/clc.20936] [Cited by in Crossref: 50] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
21 Wang X, Chen J, Yao J, Guo R. [Clinical Observation of Gefitinib with Pericardial Perfusion for 
Advanced Non-small Cell Lung Cancer]. Zhongguo Fei Ai Za Zhi 2018;21:37-42. [PMID: 29357971 DOI: 10.3779/j.issn.1009-3419.2018.01.10] [Reference Citation Analysis]
22 Chahine J, Shekhar S, Mahalwar G, Imazio M, Collier P, Klein A. Pericardial Involvement in Cancer. Am J Cardiol 2021;145:151-9. [PMID: 33460602 DOI: 10.1016/j.amjcard.2020.12.092] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
23 Dracham CB, Gupta S, Das CK, Elangovan A. Platinum sensitive carcinoma of ovary relapsed as pericardial effusion with cardiac tamponade. BMJ Case Rep 2019;12:e228268. [PMID: 30904894 DOI: 10.1136/bcr-2018-228268] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
24 Jeon HW, Cho DG, Park JK, Hyun KY, Choi SY, Suh JH, Kim YD. Prognostic factors affecting survival of patients with cancer-related pericardial effusion managed by surgery. World J Surg Oncol 2014;12:249. [PMID: 25091001 DOI: 10.1186/1477-7819-12-249] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
25 Moursy S, Gaballa S, Ahmed A, Hlaing KM, Patel BB. Impending Cardiac Tamponade as the Initial Manifestation of BCR-ABL Positive Chronic Myeloid Leukemia. Cureus 2020;12:e9631. [PMID: 32923232 DOI: 10.7759/cureus.9631] [Reference Citation Analysis]
26 El Haddad D, Iliescu C, Yusuf SW, William WN Jr, Khair TH, Song J, Mouhayar EN. Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion. J Am Coll Cardiol 2015;66:1119-28. [PMID: 26337990 DOI: 10.1016/j.jacc.2015.06.1332] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 7.1] [Reference Citation Analysis]
27 Zhang Y, Zou JY, Xu YY, He JN. Fruquintinib beneficial in elderly patient with neoplastic pericardial effusion from rectal cancer: A case report. World J Clin Cases 2021; 9(21): 6170-6177 [PMID: 34368339 DOI: 10.12998/wjcc.v9.i21.6170] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Chang HM, Okwuosa TM, Scarabelli T, Moudgil R, Yeh ETH. Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2. J Am Coll Cardiol 2017;70:2552-65. [PMID: 29145955 DOI: 10.1016/j.jacc.2017.09.1095] [Cited by in Crossref: 110] [Cited by in F6Publishing: 93] [Article Influence: 22.0] [Reference Citation Analysis]
29 Søgaard KK, Farkas DK, Ehrenstein V, Bhaskaran K, Bøtker HE, Sørensen HT. Pericarditis as a Marker of Occult Cancer and a Prognostic Factor for Cancer Mortality. Circulation 2017;136:996-1006. [PMID: 28663234 DOI: 10.1161/CIRCULATIONAHA.116.024041] [Cited by in Crossref: 34] [Cited by in F6Publishing: 8] [Article Influence: 6.8] [Reference Citation Analysis]
30 Goel K, Ateeli H, Ampel NM, L'heureux D. Patient with Small Cell Lung Carcinoma and Suspected Right Upper Lobe Abscess Presenting with a Purulent Pericardial Effusion. Am J Case Rep 2016;17:523-8. [PMID: 27443973 DOI: 10.12659/ajcr.898079] [Reference Citation Analysis]
31 Bois JP, Valles AG, Sinak LJ. 78-year-old man with metastatic squamous cell carcinoma, dyspnea, and hypotension. Mayo Clin Proc 2010;85:e78-81. [PMID: 21037039 DOI: 10.4065/mcp.2010.0097] [Reference Citation Analysis]
32 Li BT, Pearson A, Pavlakis N, Bell D, Lee A, Chan D, Harden M, Mathur M, Marshman D, Brady P, Clarke S. Malignant Cardiac Tamponade from Non-Small Cell Lung Cancer: Case Series from the Era of Molecular Targeted Therapy. J Clin Med 2014;4:75-84. [PMID: 26237019 DOI: 10.3390/jcm4010075] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
33 Zheng H, Tong L, Hu Y, Wu W, Zhang H, Li B. [Prognostic factors in 408 elderly lung cancer patients more than 70 years old]. Zhongguo Fei Ai Za Zhi 2011;14:502-6. [PMID: 21645453 DOI: 10.3779/j.issn.1009-3419.2011.06.05] [Reference Citation Analysis]
34 Lutz A, Schelbert EB, Lontos K, Rossetti J, Katz W. Acute Myeloid Leukemia Presenting as Effusive Constrictive Pericarditis. CASE (Phila) 2020;4:97-102. [PMID: 32337400 DOI: 10.1016/j.case.2019.09.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Imazio M. Pericardiocentesis With Extended Drainage and Colchicine: New Indication for Malignant Pericardial Effusions? J Am Coll Cardiol 2020;76:1562-3. [PMID: 32972533 DOI: 10.1016/j.jacc.2020.08.008] [Reference Citation Analysis]
36 Hu ZG, Hu K, Li WX, Zeng FJ. Prognostic factors and nomogram for cancer-specific death in non small cell lung cancer with malignant pericardial effusion. PLoS One 2019;14:e0217007. [PMID: 31095610 DOI: 10.1371/journal.pone.0217007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
37 Conway N, Hutchison S. Malignant pericardial effusion in a patient with prostate adenocarcinoma. BMJ Case Rep 2012;2012:bcr0120125570. [PMID: 22962367 DOI: 10.1136/bcr.01.2012.5570] [Reference Citation Analysis]
38 Ikeda H, Kikawa Y, Nakamoto Y, Takeo M, Yamamoto M. A patient with recurrent breast cancer showing long-term survival after developing pericardial effusion and cardiac tamponade caused by carcinomatous pericarditis. Breast Care (Basel) 2013;8:71-3. [PMID: 24715847 DOI: 10.1159/000346831] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
39 Yonemori K, Kunitoh H, Tsuta K, Tamura T, Arai Y, Shimada Y, Fujiwara Y, Sasajima Y, Asamura H, Tamura T. Prognostic factors for malignant pericardial effusion treated by pericardial drainage in solid-malignancy patients. Med Oncol 2007;24:425-30. [PMID: 17917093 DOI: 10.1007/s12032-007-0033-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]